Metropolitan Life Insurance CO Stoke Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.12 - $14.17 $453 - $1,558	110 Added 7.26%	1,625 $21,000
Q2 2023 Aug 10, 2023	BUY	$7.93 - $13.82 $2,022 - $3,524	255 Added 20.24%	1,515 $16,000
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $1,086 - $1,473	-142 Reduced 10.13%	1,260 $10,000
Q4 2022 Jun 14, 2023	BUY	$7.07 - $15.69 $1,003 - $2,227	142 Added 11.27%	1,402 $12.9 Million
Q4 2022 Mar 30, 2023	BUY	$7.07 - $15.69 $544 - $1,208	77 Added 5.81%	1,402 $12,000
Q4 2022 Feb 15, 2023	BUY	$7.07 - $15.69 $544 - $1,208	77 Added 5.81%	1,402 $12,000
Q3 2022 Jun 14, 2023	BUY	$12.56 - $22.53 $816 - $1,464	65 Added 5.16%	1,325 $17 Million
Q2 2022 Jun 20, 2023	BUY	$10.36 - $23.93 $673 - $1,555	65 Added 5.16%	1,325 $17,000
Q1 2022 Jun 20, 2023	BUY	$17.19 - $26.1 $1,117 - $1,696	65 Added 5.16%	1,325 $27,000
Q1 2022 Mar 30, 2023	SELL	$17.19 - $26.1 $73,727 - $111,942	-4,289 Reduced 76.4%	1,325 $27,000
Q1 2022 May 12, 2022	SELL	$17.19 - $26.1 $73,727 - $111,942	-4,289 Reduced 76.4%	1,325 $28,000
Q4 2021 Jun 21, 2023	BUY	$18.11 - $30.72 $78,850 - $133,754	4,354 Added 345.56%	5,614 $134,000
Q3 2021 Jun 21, 2023	BUY	$23.65 - $34.44 $102,972 - $149,951	4,354 Added 345.56%	5,614 $142,000
Q2 2021 Jun 21, 2023	BUY	$30.53 - $41.09 $132,927 - $178,905	4,354 Added 345.56%	5,614 $188,000
Q2 2021 Mar 30, 2023	BUY	$30.53 - $41.09 $55,992 - $75,359	1,834 Added 48.52%	5,614 $188,000
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $171,273 - $230,514	5,610 Added 140250.0%	5,614 $189,000
Q1 2021 Jun 26, 2023	BUY	$36.08 - $69.81 $90,921 - $175,921	2,520 Added 200.0%	3,780 $147 Million
Q1 2021 May 14, 2021	SELL	$36.08 - $69.81 $136,238 - $263,602	-3,776 Reduced 99.89%	4 $147,000
Q4 2020 Jun 22, 2023	BUY	$33.62 - $61.93 $84,722 - $156,063	2,520 Added 200.0%	3,780 $234,000
Q3 2020 Jun 26, 2023	BUY	$22.23 - $37.48 $56,019 - $94,449	2,520 Added 200.0%	3,780 $126,000
Q3 2020 Mar 30, 2023	SELL	$22.23 - $37.48 $38,791 - $65,402	-1,745 Reduced 31.58%	3,780 $126,000
Q3 2020 Nov 13, 2020	SELL	$22.23 - $37.48 $38,791 - $65,402	-1,745 Reduced 31.58%	3,780 $127,000
Q2 2020 Jun 26, 2023	BUY	$20.26 - $29.73 $86,408 - $126,798	4,265 Added 338.49%	5,525 $131,000
Q1 2020 Jul 12, 2023	BUY	$16.8 - $34.15 $71,652 - $145,649	4,265 Added 338.49%	5,525 $126,000
Q1 2020 Mar 30, 2023	BUY	$16.8 - $34.15 $35,616 - $72,398	2,120 Added 62.26%	5,525 $126,000
Q1 2020 May 15, 2020	BUY	$16.8 - $34.15 $35,616 - $72,398	2,120 Added 62.26%	5,525 $127,000
Q4 2019 Jul 12, 2023	BUY	$20.01 - $30.79 $42,921 - $66,044	2,145 Added 170.24%	3,405 $96,000
Q4 2019 Mar 30, 2023	BUY	$20.01 - $30.79 $40,080 - $61,672	2,003 Added 142.87%	3,405 $96,000
Q4 2019 Feb 14, 2020	BUY	$20.01 - $30.79 $68,134 - $104,839	3,405 New	3,405 $96,000

Others Institutions Holding STOK

# of Institutions

117

Shares Held

55.6M

Call Options Held

14K

Put Options Held

8.8K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $482M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account